Hepatitis C virus (HCV) FibroSure

Alphabetical Test listing

Hepatitis C virus (HCV) FibroSure-13569

  
Hepatitis C virus (HCV) FibroSure
  
13569
  
LAB13569
  
FIBRO
  
ActiTest
HCV
HCV Fibrosure
FibroSure
FibroTest
  
  • Assessment of liver status following a diagnosis of HCV
  • Baseline determination of liver status before initiating HCV therapy
  • Posttreatment assessment of liver status six months after completion of therapy
  • Noninvasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy
  

Patient should be fasting for at least eight hours prior to sample collection

Fasting for a blood test

 

  
Serum
  
  
3.5 mL
  
2.0 mL
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of specimen collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  
  
  1. Allow sample to clot
  2. Spin within two (2) hours of specimen collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  

Frozen (preferred) - 7 days

Frozen samples are stable for one freeze/thaw cycle.

Refrigerated - 72 hours

Ambient - 72 hours

 

  
  • Gross hemolysis
  • Gross lipemia
  • Improper labeling
  • Non-fasting specimen
  • Patient younger than 14 years of age
  
LabCorp Burlington (550123): R-LC
  
Mo - Fr
  
3 - 5 days
  

Fibrosis Stage (FibroTest)                      

Range

F0−No fibrosis                                

0.00−0.21

F0−F1                  

>0.21−0.27

F1−Portal fibrosis

>0.27−0.31

F1−F2                  

>0.31−0.48

F2−Bridging fibrosis with few septa

>0.48−0.58

F3−Bridging fibrosis with many septa

>0.58−0.72

F3−F4                  

>0.72−0.74

F4−Cirrhosis                                                

>0.74−1.00

 

 

Activity Stage (ActiTest)                          

Range

A0−No activity                                          

0.00−0.17

A0−A1                                                        

>0.17−0.29

A1−Minimal activity                              

>0.29−0.36

A1−A2                                                        

>0.36−0.52

A2−Moderate activity                            

>0.52−0.60

A2−A3                                  

>0.60−0.63

A3−Severe activity                                  

>0.63−1.00

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81596
  
Yes
  
Result 1975-2
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

  
04/05/2019
  
02/11/2022
  
03/01/2022